RxDoctor Payments Data

Grady Fort, MD

Pediatrics · Livingston, CANPI 1982765582

Payments from drug & device makers

$490in general payments, 2019–2025

Across 19 payments — averaging $25.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$143
  • Amgen$110
  • Pfizer$60
  • Exact Sciences$45
  • Gilead$44
  • Biohaven Pharmaceutical Holding Company Ltd.$41
  • plus $48 from 3 others

What the payments were for

  • Food & beverage$490100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$490 in reported general payments places this provider in the 70th percentile of 5,539 pediatrics providers in California.

See all pediatrics providers in California

Medicare billing

Part B allowed, 2024
$1,690
Medicare patients
91
Services billed
173

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate38$51,500
MounjaroTirzepatide47$48,190
TrulicityDulaglutide28$29,897
Breztri AerosphereBudesonide/Glycopyr/Formoterol48$28,522
XareltoRivaroxaban18$26,374
EliquisApixaban24$25,869
OzempicSemaglutide17$23,299
ZenpepLipase/Protease/Amylase11$17,851
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog17$12,749
Breo ElliptaFluticasone/Vilanterol27$11,605
Spiriva HandihalerTiotropium Bromide12$10,935
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen112$4,551
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen88$4,358
Lisdexamfetamine Dimesylate13$3,286
Tramadol Hcl48$2,987

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Olanzapine$15$78,87099 claims
PfizerNurtec Odt, Eliquis$60$77,36962 claims
AstraZenecaBreztri Aerosphere$143$28,52248 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 5,539 pediatrics providers in California.

Other pediatrics in Livingston

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →